CanSino Biologics
IPO康希诺生物
Public · Tianjin, China · Founded 2009 · $10.0M raised
- Headquarters
- Tianjin
- Employees
- 1001–5000
- Founded
- 2009
- Business Model
- B2B
- Website
- cansinotech.com
- Total Funding
- $10.0M
- Last Round
- Series BJan 2017
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Chinese biopharmaceutical company developing and commercializing innovative vaccines for global public health needs.
Summary
CanSino Biologics is a Healthcare company based in Tianjin, China, founded in 2009. It has raised $10.0M in total across 2 rounds, most recently a Series B round in Jan 2017. Investors include Lilly Asia Ventures, Qiming VP and SDIC Fund Management.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2020
Sign up to see all 4 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cansino-biologics"><img src="https://indexed.vc/api/badge/company/cansino-biologics" alt="CanSino Biologics on Indexed.vc" width="260" height="76" /></a>